Evidence map›Paper›PMID 34452228›Full record

ArticlePharmaceutics2021

Stability of Hydrocortisone in Oral Powder Form Compounded for Pediatric Patients in Japan.

Jumpei Saito, Nozomi Yoshikawa, Takehisa Hanawa, Ayuna Ozawa, Takahiro Matsumoto, Tsutomu Harada, Kana Iwahashi, Hidefumi Nakamura, Akimasa Yamatani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jumpei SaitoDepartment of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.ORCID 0000-0003-4799-5562
Nozomi YoshikawaDepartment of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.
Takehisa HanawaFaculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan.ORCID 0000-0002-3922-025X
Ayuna OzawaFaculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan.
Takahiro MatsumotoR&D Center, Ohara Pharmaceutical Co., Ltd., Koka-shi 520-3403, Japan.
Tsutomu HaradaDivision of Pharmaceutics, School of Pharmacy, Showa University, Tokyo 142-8555, Japan.ORCID 0000-0002-4617-0019
Kana IwahashiDepartment of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.
Hidefumi NakamuraDepartment of Research and Development Supervision, National Center for Child Health and Development, Tokyo 157-0054, Japan.ORCID 0000-0003-0191-2450
Akimasa YamataniDepartment of Pharmacy, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-0054, Japan.
National Center For Child Health and Development · JPTokyo University of Science · JPShowa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrocortisone has been utilized in the management of adrenal insufficiency. For pediatric patients, the commercially available enteral form of hydrocortisone tablets (Cortoril

Indexed as

hydrocortisoneoral powderpediatric formulationquality assurancestability

Identifiers

PMID34452228
PMCPMC8400744
OpenAlexW3194399643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.